Literature DB >> 33742364

Authors' Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.

Janet Pope1, Ruta Sawant2, Namita Tundia2, Ella X Du3, Cynthia Z Qi4, Yan Song4, Patrick Tang4, Keith A Betts3.   

Abstract

Entities:  

Keywords:  Clinical remission; Disease-modifying antirheumatic drugs; Janus kinase inhibitors; Network meta-analysis; Rheumatoid arthritis

Year:  2021        PMID： 33742364     DOI： 10.1007/s12325-021-01642-9

Source DB:  PubMed          Journal:  Adv Ther        ISSN： 0741-238X            Impact factor:   3.845


× No keyword cloud information.
  1 in total

1.  Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Z Rheumatol       Date:  2020-10       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.